- Website
- acerta-pharma.com
- Acquisition Date
- Dec 2015
Indexed holds 1 investor for this company. The full record is or through the API.
About
Acerta Pharma is AstraZeneca's European research and development centre in the Netherlands, focused on discovering and developing novel therapies. The organization applies covalent-binding technology to create highly selective medicines and develops treatments from chemistry through clinical evidence. Its work concentrates on hematology and hematologic conditions, including the development of acalabrutinib, a selective Bruton's tyrosine kinase inhibitor.
Summary
Acerta Pharma is a Biotech company. Investors include AstraZeneca.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Exit History
Dec 2015
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/acerta-pharma"><img src="https://indexed.vc/api/badge/company/acerta-pharma" alt="Acerta Pharma on Indexed.vc" width="260" height="76" /></a>